Preliminary results of capecitabine - oxaliplatin (XELOX) in hepatocellular carcinoma (HCC): a phase II trial of the Fédération Francophone de Cancérologie Digestive (FFCD 2003 - 03 trial). - Boige,V.; Raoul,J.; Pignon,J. (Proc ASCO, 2005)